Cancer Associated Fibroblasts: An Understudied but Critical Component of the Tumor Microenvironment in Urothelial Cancer
- PMID: 37268449
- PMCID: PMC10472269
- DOI: 10.1016/j.euo.2023.05.005
Cancer Associated Fibroblasts: An Understudied but Critical Component of the Tumor Microenvironment in Urothelial Cancer
Conflict of interest statement
Sean Clark-Garvey and Jeffrey S. Damrauer have nothing to disclose. Matthew I. Milowsky holds stock in Pfizer, Merck, and Gilead Sciences; has a consulting/advisory role with Loxo/Lilly; has received research funding from Merck, Roche/Genentech, Bristol-Myers Squibb, Mirati, Incyte, Seagen, G1 Therapeutics, Alliance Foundation Trials, Alliance for Clinical Trials in Oncology, Clovis Oncology, Arvinas, ALX Oncology, Loxo, and the Hoosier Cancer Research Network; and has relationships with Elsevier, Medscape, and Research to Practice.
Comment on
-
Cancer-associated Fibroblasts in Bladder Cancer: Origin, Biology, and Therapeutic Opportunities.Eur Urol Oncol. 2023 Aug;6(4):366-375. doi: 10.1016/j.euo.2023.02.011. Epub 2023 Mar 6. Eur Urol Oncol. 2023. PMID: 36890105 Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical